CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.Marquee-fund ownership over time
This quarter's activity
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Bridgewater Associates re-entered | Q4 2014 | 47Q | $65 | $150 | +131% |
| Maverick Capital re-entered | Q4 2020 | 23Q | $238 | $150 | -37% |
| Citadel Advisors | Q3 2024(8Q snapshot) | 7Q | $199 | $150 | -24% |
| Two Sigma Investments | Q3 2024(8Q snapshot) | 7Q | $199 | $150 | -24% |
| AQR Capital Management | Q3 2024(8Q snapshot) | 7Q | $199 | $150 | -24% |
| Millennium Management | Q3 2024(8Q snapshot) | 7Q | $199 | $150 | -24% |
| D.E. Shaw re-entered | Q1 2025(8Q snapshot) | 5Q | $152 | $150 | -1% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Soros Fund Management | Q1 2026 | Q2 2026 | → $151 | -7% |
| Point72 Asset Management 2× in & out | Q1 2026 | Q2 2026 | → $151 | -5% |
| Renaissance Technologies | Q1 2026 | Q2 2026 | → $159 | +0% |
| D1 Capital Partners | Q1 2025 | Q3 2025 | → $156 | +3% |
| Viking Global Investors | Q2 2021 | Q3 2023 | → $217 | -33% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Jun 8, 2026 — the most recent Form 4 on file — not from today.
- Form 40001100682-26-000109Jun 8, 2026
- Form 40001100682-26-000107Jun 8, 2026
- Form 40001100682-26-000105Jun 8, 2026
- Form 40001100682-26-000103Jun 3, 2026
- Form 40001100682-26-000101Jun 2, 2026
- Form 40001100682-26-000099Jun 2, 2026
- Form 40001100682-26-000097Jun 2, 2026
- Form 40001100682-26-000095Jun 2, 2026
- Form 40001100682-26-000093Jun 2, 2026
- Form 40001100682-26-000091Jun 2, 2026
- Form 40001100682-26-000089Jun 2, 2026
- Form 40001100682-26-000087Jun 2, 2026
- Form 40001100682-26-000085May 28, 2026
- Form 40001100682-26-000083May 28, 2026
- Form 40001100682-26-000081May 28, 2026
Fundamentals
XBRL · CHARLES RIVER LABORATORIES INTERNATIONAL, INC.Annual figures sourced directly from CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KFORM 8-KMay 11, 2026
- 10-QQuarterly reportMay 7, 2026
- 8-KMaterial eventMay 7, 2026
- DEF 14AProxy statementMar 31, 2026
- 8-KMaterial eventFeb 25, 2026
- 8-KFORM 8-KFeb 18, 2026
- 10-KAnnual reportFeb 18, 2026
- 8-KMaterial eventFeb 18, 2026
- 8-KMaterial eventJan 13, 2026
- 8-KMaterial eventJan 9, 2026
- 8-KMaterial eventDec 3, 2025
- 8-KMaterial eventNov 17, 2025
- 10-QQuarterly reportNov 5, 2025
- 8-KMaterial eventNov 5, 2025
- 8-K/AFORM 8-K/ASep 19, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Maverick Capital | Q2 2026 | open | $151 | $175 | +16% |
| Point72 Asset Management | Q1 2026 | Q2 2026 | $159 | $151 | -5% |
| Soros Fund Management | Q1 2026 | Q2 2026 | $161 | $151 | -7% |
| Renaissance Technologies | Q1 2026 | Q2 2026 | $159 | $159 | +0% |
| Bridgewater Associates | Q4 2025 | open | $169 | $175 | +3% |
| D.E. Shaw | Q3 2025 | open | $156 | $150 | -4% |
| Point72 Asset Management | Q3 2025 | Q4 2025 | $156 | $168 | +8% |
| D1 Capital Partners | Q1 2025 | Q3 2025 | $152 | $156 | +3% |
| D.E. Shaw | Q1 2025 | Q2 2025 | $152 | $139 | -9% |
| Citadel Advisors | Q3 2024 | open | $199 | $150 | -24% |
| Two Sigma Investments | Q3 2024 | open | $199 | $150 | -24% |
| AQR Capital Management | Q3 2024 | open | $199 | $150 | -24% |
| Millennium Management | Q3 2024 | open | $199 | $150 | -24% |
| Bridgewater Associates | Q4 2021 | Q3 2024 | $386 | $199 | -49% |
| Viking Global Investors | Q2 2021 | Q3 2023 | $323 | $217 | -33% |
| Maverick Capital | Q2 2021 | Q4 2021 | $323 | $385 | +19% |
| Maverick Capital | Q4 2020 | Q1 2021 | $238 | $287 | +20% |
| Bridgewater Associates | Q4 2019 | Q1 2020 | $137 | $172 | +26% |
| Bridgewater Associates | Q2 2018 | Q2 2019 | $104 | $132 | +26% |
| Bridgewater Associates | Q3 2017 | Q1 2018 | $97 | $108 | +11% |
| Bridgewater Associates | Q4 2015 | Q2 2016 | $71 | $83 | +16% |
| Bridgewater Associates | Q4 2014 | Q3 2015 | $65 | $75 | +16% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.